国产麻豆福利AV在线观看,五月色网站

您好，歡迎來到拜力生物網(wǎng)站！請登錄注冊

我的訂單 | 聯(lián)系我們 | 在線客服QQ：3012681483 | 客服電話：400-968-7988 | 工作時間：08:30-17:30

主營產(chǎn)品： ELISA試劑盒、抗體、補體血清、兔補體、干擾素、小鼠測溫儀、進口試劑、Quidel代理、Swant代理、PBL Assay Science代理

網(wǎng)站首頁產(chǎn)品中心代理品牌新聞資訊資源中心關(guān)于我們

所在位置：首頁 > 產(chǎn)品中心 > Antibodies > Antibodies產(chǎn)品

訂購信息

上海拜力生物科技公司

Tel:400-968-7988 021-33779008

Anti-OPG (P25) Antibody

品牌：Antibodies

貨號：

規(guī)格：50μl

貨期：

應(yīng)用：

咨詢客服

立即購買加入購物車

Anti-OPG (P25) Antibody

商品詳情參考文獻相關(guān)資料

Overview

Name:	Anti-OPG (P25) Antibody See all OPG primary antibodies
Description:	Rabbit polyclonal antibody to OPG (P25)
Specificity:	OPG (P25) pAb detects endogenous levels of Osteoprotegerin protein.
Applications:	WB, IHC, IF
Reactivity:	Human, Mouse, Rat
Immunogen:	Synthetic peptide, corresponding to amino acids 1-50 of Human OPG.
Host:	Rabbit
Clonality:	Polyclonal
Conjugate:	Unconjugated
Molecular Weight:	~ 46 kDa
Purity:	The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen and the purity is > 95% (by SDS-PAGE).
Product Form:	1 mg/ml in Phosphate buffered saline (PBS) with 15 mM sodium azide, approx. pH 7.2.

Target

Function:	Acts as decoy receptor for TNFSF11/RANKL and thereby neutralizes its function in osteoclastogenesis. Inhibits the activation of osteoclasts and promotes osteoclast apoptosis in vitro. Bone homeostasis seems to depend on the local ratio between TNFSF11 and TNFRSF11B. May also play a role in preventing arterial calcification. May act as decoy receptor for TNFSF10/TRAIL and protect against apoptosis. TNFSF10/TRAIL binding blocks the inhibition of osteoclastogenesis.
Tissue Specificity:	Highly expressed in ***** lung, heart, kidney, liver, spleen, thymus, prostate, ovary, small intestine, thyroid, lymph node, trachea, adrenal gland, testis, and bone marrow. Detected at very low levels in brain, placenta and skeletal muscle. Highly expressed in fetal kidney, liver and lung.
Involvement in Disease:	Paget disease of bone 5, juvenile-onset: An autosomal recessive, juvenile-onset form of Paget disease, a disorder of bone remodeling characterized by increased bone turnover affecting one or more sites throughout the skeleton, primarily the axial skeleton. Osteoclastic overactivity followed by compensatory osteoblastic activity leads to a structurally disorganized mosaic of bone (woven bone), which is mechanically weaker, larger, less compact, more vascular, and more susceptible to fracture than normal ***** lamellar bone. PDB5 clinical manifestations include short stature, progressive long bone deformities, fractures, vertebral collapse, skull enlargement, and hyperostosis with progressive deafness.
Post-Translational Modification:	N-glycosylated. Contains sialic acid residues.
Cellular Location:	Secreted.
Database Links:	Entrez Gene: 4982?Human Entrez Gene: 18383?Mouse Entrez Gene: 25341?Rat Omim: 602643?Human SwissProt: O00300?Human SwissProt: O08712?Mouse SwissProt: O08727?Rat Unigene: 81791?Human Unigene: 15383?Mouse Unigene: 202973?Rat
Synonyms:	MGC29565 Antibody MGC93568 Antibody OCIF Antibody OPG Antibody Osteoclastogenesis inhibitory factor Antibody Osteoprotegerin Antibody PDB5 Antibody TNF receptor superfamily member 11b Antibody TNFRSF 11B Antibody TNFRSF11B Antibody TR 1 Antibody TR1 Antibody TR11B_HUMAN Antibody Tumor necrosis factor receptor superfamily member 11B Antibody
Information:	Target information shown above is from the UniProt Consortium.